Key Points
- Liquidia CEO Roger Jeffs sold 25,000 shares on April 9 at an average of $40.12 for about $1.003 million, reducing his holding by 1.62% to 1,516,667 shares; the transaction was executed under a pre-arranged Rule 10b5-1 trading plan and disclosed in an SEC filing.
- Liquidia recently reported a quarterly beat (EPS $0.15 vs. $0.08 consensus and $92.02M revenue), but still posts negative ROE/net margin and analysts expect a full-year EPS of -1.51; the stock trades in the mid-$30s with an average analyst target of about $43.44.
Liquidia Corporation (NASDAQ:LQDA - Get Free Report) CEO Roger Jeffs sold 25,000 shares of the stock in a transaction that occurred on Thursday, April 9th. The stock was sold at an average price of $40.12, for a total value of $1,003,000.00. Following the transaction, the chief executive officer directly owned 1,516,667 shares in the company, valued at approximately $60,848,680.04. This represents a 1.62% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Liquidia Price Performance
Shares of NASDAQ LQDA opened at $38.85 on Tuesday. The company has a current ratio of 2.01, a quick ratio of 1.84 and a debt-to-equity ratio of 2.97. The company has a market capitalization of $3.42 billion, a price-to-earnings ratio of -46.81 and a beta of 0.45. Liquidia Corporation has a twelve month low of $11.85 and a twelve month high of $46.67. The business has a 50 day simple moving average of $36.87 and a 200-day simple moving average of $32.92.
Liquidia (NASDAQ:LQDA - Get Free Report) last announced its quarterly earnings data on Thursday, March 5th. The company reported $0.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.08 by $0.07. The firm had revenue of $92.02 million for the quarter, compared to analysts' expectations of $87.49 million. Liquidia had a negative return on equity of 209.33% and a negative net margin of 43.53%.The firm's revenue for the quarter was up 3072.4% compared to the same quarter last year. As a group, equities research analysts expect that Liquidia Corporation will post -1.51 earnings per share for the current year.
Hedge Funds Weigh In On Liquidia
Several institutional investors have recently modified their holdings of LQDA. Covestor Ltd increased its holdings in shares of Liquidia by 41.9% in the 4th quarter. Covestor Ltd now owns 1,216 shares of the company's stock worth $42,000 after acquiring an additional 359 shares during the period. PNC Financial Services Group Inc. boosted its stake in Liquidia by 7.2% during the 4th quarter. PNC Financial Services Group Inc. now owns 6,304 shares of the company's stock valued at $217,000 after purchasing an additional 422 shares during the period. Whitcomb & Hess Inc. grew its position in Liquidia by 2.0% in the 3rd quarter. Whitcomb & Hess Inc. now owns 28,385 shares of the company's stock worth $645,000 after purchasing an additional 558 shares during the last quarter. Northwestern Mutual Wealth Management Co. bought a new position in Liquidia in the 4th quarter worth about $25,000. Finally, ProShare Advisors LLC increased its stake in shares of Liquidia by 7.1% in the fourth quarter. ProShare Advisors LLC now owns 11,756 shares of the company's stock valued at $405,000 after purchasing an additional 775 shares during the period. Institutional investors own 64.54% of the company's stock.
Analyst Upgrades and Downgrades
Several research analysts have recently commented on LQDA shares. Oppenheimer lifted their price target on shares of Liquidia from $16.00 to $19.00 and gave the company an "underperform" rating in a report on Thursday, March 12th. Zacks Research cut shares of Liquidia from a "strong-buy" rating to a "hold" rating in a report on Friday, February 27th. Raymond James Financial restated a "strong-buy" rating on shares of Liquidia in a research note on Thursday, March 5th. Needham & Company LLC upped their target price on Liquidia from $52.00 to $54.00 and gave the company a "buy" rating in a report on Thursday, March 5th. Finally, Lifesci Capital upgraded Liquidia to a "strong-buy" rating in a research report on Thursday, March 5th. Two research analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating, one has issued a Hold rating and two have given a Sell rating to the company's stock. According to data from MarketBeat, Liquidia has an average rating of "Moderate Buy" and an average target price of $43.44.
Check Out Our Latest Stock Report on LQDA
About Liquidia
(
Get Free Report)
Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.
The company's lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
